Report Detail

Pharma & Healthcare Global Preventive Medicine for Pets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4744616
  • |
  • 28 September, 2026
  • |
  • Global
  • |
  • 121 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Preventive Medicine for Pets market size was valued at US$ 1180 million in 2025 and is forecast to a readjusted size of US$ 1987 million by 2032 with a CAGR of 7.8% during review period.
Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 50%.
This report is a detailed and comprehensive analysis for global Preventive Medicine for Pets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Preventive Medicine for Pets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Preventive Medicine for Pets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Preventive Medicine for Pets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Preventive Medicine for Pets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Preventive Medicine for Pets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Preventive Medicine for Pets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Preventive Medicine for Pets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Powder
Liquid
Market segment by Application
Cat
Dog
Reptile
Other
Major players covered
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan chopperlvya
CAHIC
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Preventive Medicine for Pets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Preventive Medicine for Pets, with price, sales quantity, revenue, and global market share of Preventive Medicine for Pets from 2021 to 2026.
Chapter 3, the Preventive Medicine for Pets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Preventive Medicine for Pets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Preventive Medicine for Pets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Preventive Medicine for Pets.
Chapter 14 and 15, to describe Preventive Medicine for Pets sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Preventive Medicine for Pets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Powder
    • 1.3.3 Liquid
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Preventive Medicine for Pets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cat
    • 1.4.3 Dog
    • 1.4.4 Reptile
    • 1.4.5 Other
  • 1.5 Global Preventive Medicine for Pets Market Size & Forecast
    • 1.5.1 Global Preventive Medicine for Pets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Preventive Medicine for Pets Sales Quantity (2021-2032)
    • 1.5.3 Global Preventive Medicine for Pets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Zoetis
    • 2.1.1 Zoetis Details
    • 2.1.2 Zoetis Major Business
    • 2.1.3 Zoetis Preventive Medicine for Pets Product and Services
    • 2.1.4 Zoetis Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Zoetis Recent Developments/Updates
  • 2.2 Boehringer Ingelheim
    • 2.2.1 Boehringer Ingelheim Details
    • 2.2.2 Boehringer Ingelheim Major Business
    • 2.2.3 Boehringer Ingelheim Preventive Medicine for Pets Product and Services
    • 2.2.4 Boehringer Ingelheim Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Preventive Medicine for Pets Product and Services
    • 2.3.4 Merck Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Merck Recent Developments/Updates
  • 2.4 Elanco
    • 2.4.1 Elanco Details
    • 2.4.2 Elanco Major Business
    • 2.4.3 Elanco Preventive Medicine for Pets Product and Services
    • 2.4.4 Elanco Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Elanco Recent Developments/Updates
  • 2.5 Virbac
    • 2.5.1 Virbac Details
    • 2.5.2 Virbac Major Business
    • 2.5.3 Virbac Preventive Medicine for Pets Product and Services
    • 2.5.4 Virbac Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Virbac Recent Developments/Updates
  • 2.6 Dechra Veterinary Products
    • 2.6.1 Dechra Veterinary Products Details
    • 2.6.2 Dechra Veterinary Products Major Business
    • 2.6.3 Dechra Veterinary Products Preventive Medicine for Pets Product and Services
    • 2.6.4 Dechra Veterinary Products Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Dechra Veterinary Products Recent Developments/Updates
  • 2.7 Ceva
    • 2.7.1 Ceva Details
    • 2.7.2 Ceva Major Business
    • 2.7.3 Ceva Preventive Medicine for Pets Product and Services
    • 2.7.4 Ceva Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Ceva Recent Developments/Updates
  • 2.8 Vetoquinol
    • 2.8.1 Vetoquinol Details
    • 2.8.2 Vetoquinol Major Business
    • 2.8.3 Vetoquinol Preventive Medicine for Pets Product and Services
    • 2.8.4 Vetoquinol Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Vetoquinol Recent Developments/Updates
  • 2.9 Ouro Fino Saude
    • 2.9.1 Ouro Fino Saude Details
    • 2.9.2 Ouro Fino Saude Major Business
    • 2.9.3 Ouro Fino Saude Preventive Medicine for Pets Product and Services
    • 2.9.4 Ouro Fino Saude Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Ouro Fino Saude Recent Developments/Updates
  • 2.10 Norbrook
    • 2.10.1 Norbrook Details
    • 2.10.2 Norbrook Major Business
    • 2.10.3 Norbrook Preventive Medicine for Pets Product and Services
    • 2.10.4 Norbrook Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Norbrook Recent Developments/Updates
  • 2.11 Jindun
    • 2.11.1 Jindun Details
    • 2.11.2 Jindun Major Business
    • 2.11.3 Jindun Preventive Medicine for Pets Product and Services
    • 2.11.4 Jindun Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Jindun Recent Developments/Updates
  • 2.12 Wuhan chopperlvya
    • 2.12.1 Wuhan chopperlvya Details
    • 2.12.2 Wuhan chopperlvya Major Business
    • 2.12.3 Wuhan chopperlvya Preventive Medicine for Pets Product and Services
    • 2.12.4 Wuhan chopperlvya Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Wuhan chopperlvya Recent Developments/Updates
  • 2.13 CAHIC
    • 2.13.1 CAHIC Details
    • 2.13.2 CAHIC Major Business
    • 2.13.3 CAHIC Preventive Medicine for Pets Product and Services
    • 2.13.4 CAHIC Preventive Medicine for Pets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 CAHIC Recent Developments/Updates

3 Competitive Environment: Preventive Medicine for Pets by Manufacturer

  • 3.1 Global Preventive Medicine for Pets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Preventive Medicine for Pets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Preventive Medicine for Pets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Preventive Medicine for Pets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Preventive Medicine for Pets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Preventive Medicine for Pets Manufacturer Market Share in 2025
  • 3.5 Preventive Medicine for Pets Market: Overall Company Footprint Analysis
    • 3.5.1 Preventive Medicine for Pets Market: Region Footprint
    • 3.5.2 Preventive Medicine for Pets Market: Company Product Type Footprint
    • 3.5.3 Preventive Medicine for Pets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Preventive Medicine for Pets Market Size by Region
    • 4.1.1 Global Preventive Medicine for Pets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Preventive Medicine for Pets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Preventive Medicine for Pets Average Price by Region (2021-2032)
  • 4.2 North America Preventive Medicine for Pets Consumption Value (2021-2032)
  • 4.3 Europe Preventive Medicine for Pets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Preventive Medicine for Pets Consumption Value (2021-2032)
  • 4.5 South America Preventive Medicine for Pets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Preventive Medicine for Pets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Preventive Medicine for Pets Sales Quantity by Type (2021-2032)
  • 5.2 Global Preventive Medicine for Pets Consumption Value by Type (2021-2032)
  • 5.3 Global Preventive Medicine for Pets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Preventive Medicine for Pets Sales Quantity by Application (2021-2032)
  • 6.2 Global Preventive Medicine for Pets Consumption Value by Application (2021-2032)
  • 6.3 Global Preventive Medicine for Pets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Preventive Medicine for Pets Sales Quantity by Type (2021-2032)
  • 7.2 North America Preventive Medicine for Pets Sales Quantity by Application (2021-2032)
  • 7.3 North America Preventive Medicine for Pets Market Size by Country
    • 7.3.1 North America Preventive Medicine for Pets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Preventive Medicine for Pets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Preventive Medicine for Pets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Preventive Medicine for Pets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Preventive Medicine for Pets Market Size by Country
    • 8.3.1 Europe Preventive Medicine for Pets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Preventive Medicine for Pets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Preventive Medicine for Pets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Preventive Medicine for Pets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Preventive Medicine for Pets Market Size by Region
    • 9.3.1 Asia-Pacific Preventive Medicine for Pets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Preventive Medicine for Pets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Preventive Medicine for Pets Sales Quantity by Type (2021-2032)
  • 10.2 South America Preventive Medicine for Pets Sales Quantity by Application (2021-2032)
  • 10.3 South America Preventive Medicine for Pets Market Size by Country
    • 10.3.1 South America Preventive Medicine for Pets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Preventive Medicine for Pets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Preventive Medicine for Pets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Preventive Medicine for Pets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Preventive Medicine for Pets Market Size by Country
    • 11.3.1 Middle East & Africa Preventive Medicine for Pets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Preventive Medicine for Pets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Preventive Medicine for Pets Market Drivers
  • 12.2 Preventive Medicine for Pets Market Restraints
  • 12.3 Preventive Medicine for Pets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Preventive Medicine for Pets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Preventive Medicine for Pets
  • 13.3 Preventive Medicine for Pets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Preventive Medicine for Pets Typical Distributors
  • 14.3 Preventive Medicine for Pets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Preventive Medicine for Pets. Industry analysis & Market Report on Preventive Medicine for Pets is a syndicated market report, published as Global Preventive Medicine for Pets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Preventive Medicine for Pets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report